Related references
Note: Only part of the references are listed.Transforming growth factor--sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells
Xiujuan Liu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation
Heather W. Stout-Delgado et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease
Seonmin Lee et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
Mian Cheng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT
Kaiming Wu et al.
CLINICAL SCIENCE (2016)
NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung
Ismini Lasithiotaki et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts
Guangzao Li et al.
EXPERIMENTAL CELL RESEARCH (2016)
Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis
Saeideh Jafarinejad-Farsangi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
Isis Ludwig-Portugall et al.
KIDNEY INTERNATIONAL (2016)
MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease
Ayano Takeuchi-Yorimoto et al.
TOXICOLOGY LETTERS (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts
Nadia A. Hasaneen et al.
RESPIRATORY RESEARCH (2016)
Molecular Activation of the NLRP3 Inflammasome in Fibrosis: Common Threads Linking Divergent Fibrogenic Diseases
Carol M. Artlett et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
The Angiotensin-Converting Enzyme 2/Angiotensin (1-7)/Mas Axis Protects Against Lung Fibroblast Migration and Lung Fibrosis by Inhibiting the NOX4-Derived ROS-Mediated RhoA/Rho Kinase Pathway
Ying Meng et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice
Lifang Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
MicroRNA-21: A Central Regulator of Fibrotic Diseases Via Various Targets
Ying Huang et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis
Johan M. Lorenzen et al.
EUROPEAN HEART JOURNAL (2015)
Vector-mediated microRNA-21 silencing ameliorates granulomatous liver fibrosis in Schistosoma japonicum infection
Martina Sombetzki et al.
HEPATOLOGY (2015)
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways
Ivan G. Gomez et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Modulation of angiotensin II signaling in the prevention of fibrosis
Amanda M. Murphy et al.
FIBROGENESIS & TISSUE REPAIR (2015)
Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
Ying Meng et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis
Edwin Roger Parra et al.
CLINICS (2014)
Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling
Maria Jose Acuna et al.
HUMAN MOLECULAR GENETICS (2014)
Tanshinone IIA Attenuates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/Angiotensin-(1-7) Axis in Rats
Huajie Wu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Angiotensin-(1-7): beyond the cardio-renal actions
Danielle G. Passos-Silva et al.
CLINICAL SCIENCE (2013)
The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells
Mitsuhiro Yamada et al.
RESPIRATORY RESEARCH (2013)
Role of miR-21 in the pathogenesis of atrial fibrosis
Oliver Adam et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation
Min Ling et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Inflammasomes in liver diseases
Gyongyi Szabo et al.
JOURNAL OF HEPATOLOGY (2012)
MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases
Si Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
The Angiotensin-Converting Enzyme 2/Angiogenesis-(1-7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension
Vinayak Shenoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Gang Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Inflammation and Fibrosis during Chlamydia pneumoniae Infection Is Regulated by IL-1 and the NLRP3/ASC Inflammasome
Xianbao He et al.
JOURNAL OF IMMUNOLOGY (2010)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis
Xiaopeng Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Share Paper
